tradmap

TARA Earnings Protara Therapeutics, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$6 -$3 $0 2021 2022 2023 2024 2025
EPS
Net income (annual)
-$66M -$33M $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Net income
Return on equity (annual)
-434% -33% 368% 0% 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
ROE

Quarterly results

Diluted EPS (quarterly)
-$3 -$1 $0 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26
EPS
Net income (quarterly)
-$22M -$11M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income
Return on equity (quarterly)
-19% -9% 0% Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
ROE

Reported EPS history

1–21 of 21
Q2 20262026-06-30-0.672026-08-1110-Q
Q1 20262026-03-31-0.312026-05-1310-Q
FY 20252025-12-31-1.342026-03-1010-K
Q3 20252025-09-30-0.962025-11-1010-Q
Q2 20262025-06-30-0.652026-08-1110-Q
Q1 20262025-03-31-0.292026-05-1310-Q
FY 20252024-12-31-2.172026-03-1010-K
Q3 20252024-09-30-1.742025-11-1010-Q
Q2 20252024-06-30-1.262025-08-1110-Q
Q1 20252024-03-31-0.972025-05-0810-Q
FY 20242023-12-31-3.572025-03-0510-K
Q3 20242023-09-30-2.672024-11-1210-Q
Q2 20242023-06-30-1.802024-08-0610-Q
Q1 20242023-03-31-0.802024-05-0210-Q
FY 20232022-12-31-5.862024-03-1310-K
Q3 20232022-09-30-2.402023-11-0310-Q
Q2 20232022-06-30-1.712023-08-0310-Q
Q1 20232022-03-31-0.962023-05-0410-Q
FY 20222021-12-31-4.212023-03-0810-K
Q3 20222021-09-30-3.302022-11-0310-Q
Q2 20222021-06-30-2.342022-08-0910-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.